Si-Bone (SIBN) FCF Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Si-Bone | 611.92 Mn | 471.80 Mn | 41.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -873.00 |
| Dec 31, 2025 | -243.00 |
| Sep 30, 2025 | 315.00 |
| Jun 30, 2025 | 1,729.00 |
| Mar 31, 2025 | -3,277.00 |
| Dec 31, 2024 | 3,445.00 |
| Sep 30, 2024 | -258.00 |
| Jun 30, 2024 | 1,162.00 |
| Mar 31, 2024 | -1,860.00 |
| Dec 31, 2023 | -1,601.00 |
| Sep 30, 2023 | 2,804.00 |
| Jun 30, 2023 | 2,183.00 |
| Mar 31, 2023 | -4,063.00 |
| Dec 31, 2022 | 3,807.00 |
| Sep 30, 2022 | 2,762.00 |
| Jun 30, 2022 | 452.00 |
| Mar 31, 2022 | -1,982.00 |
| Dec 31, 2021 | -2,544.00 |
| Sep 30, 2021 | 2,161.00 |
| Jun 30, 2021 | 874.00 |
| Mar 31, 2021 | -1,617.00 |
| Dec 31, 2020 | -418.00 |
| Sep 30, 2020 | 2,160.00 |
| Jun 30, 2020 | -78.00 |
| Mar 31, 2020 | -626.00 |
| Dec 31, 2019 | -105.00 |
| Sep 30, 2019 | 746.00 |
| Jun 30, 2019 | -792.00 |
| Mar 31, 2019 | -191.00 |
| Dec 31, 2018 | -2,780.00 |
| Sep 30, 2018 | -1,009.00 |
| Jun 30, 2018 | 2,806.00 |
| Mar 31, 2018 | -632.00 |